Results 211 to 220 of about 4,684,794 (400)
Deep learning‐based prediction model for operative mortality using the National Clinical Database (NCD). The model achieved a C‐statistic of 0.74. ABSTRACT Background Radical gastrectomy with lymph node dissection is the primary treatment for gastric cancer.
Ryosuke Fukuyo+5 more
wiley +1 more source
Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant Therapy [PDF]
Mark H. Eckman+2 more
openalex +1 more source
How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy.
S. Schulman
semanticscholar +1 more source
ABSTRACT Breakthrough hemolysis (BTH) is defined as a hemolytic exacerbation in a patient with paroxysmal nocturnal hemoglobinuria (PNH) treated with complement inhibitors (CIs). In the current era of several terminal and proximal inhibitors, there are no guidelines for defining BTH and its severity, and clinical management is not standardized.
Bruno Fattizzo+23 more
wiley +1 more source
Pharmacists' Knowledge of Abnormal Uterine Bleeding in Women on Anticoagulant Therapy: A French Survey. [PDF]
Frerebeau S+3 more
europepmc +1 more source
Prophylactic low dose heparin anticoagulant therapy in patients with spinal cord injuries: a retrospective study [PDF]
Jai Kulkarni+3 more
openalex +1 more source
Trametinib in Adults with Neurofibromatosis Type 1‐Related Symptomatic Plexiform Neurofibromas
Objective Mitogen‐activated protein kinase kinase inhibitors have shown promising results in treatment of plexiform neurofibromas in neurofibromatosis type 1 patients, but data in adults are limited. The aim of this phase 2 study was to investigate the efficacy and safety of trametinib in adults with neurofibromatosis type 1.
D. Christine Noordhoek+7 more
wiley +1 more source
Oral anticoagulant therapy. Urgent need for standardization. [PDF]
J. Hirsh
openalex +1 more source